COURSE INFORMATION
This webinar introduces the principles and clinical applications of CT-based lung cancer screening, focusing on the interpretation of screen-detected abnormalities at baseline and follow-up screening examinations.
Faculty will provide an overview of structured reading strategies with and without computer-aided detection (CAD), pulmonary nodule morphology, volumetric assessment, volume doubling time (VDT), and the recognition of benign, malignant, and indeterminate findings commonly encountered in screening practice.
Participants will gain insight into the assessment of solid and subsolid nodules, intrapulmonary lymph nodes, infection-related findings, cystic and mediastinal malignancies, CAD detections and misses, as well as common pitfalls in growth assessment and the evaluation of newly detected nodules.
The webinar aims to enhance participants' understanding of contemporary lung cancer screening interpretation, the strengths and limitations of CAD and volumetry, and the assessment of longitudinal change, while preparing them for the interactive case-based workshop.
LEARNING OBJECTIVES
- Understand the principles of lung cancer screening with low-dose CT, including how balancing harm and benefit underscores approaches to nodule detection, characterisation, and risk assessment.
- Identify key concepts underpinning contemporary nodule guidelines with respect to baseline and follow-up nodule interpretation, differentiation of benign and malignant lesions, growth, and the assessment of newly detected or changing nodules.
- Recognise strategies in maximising detection and interpretation of actionable nodules, including the benefits and limitations of assistance with computer-aided detection (CAD).
- Develop an understanding of an evidence-based approach to incidental findings in lung cancer screening.
PROGRAMME ONLINE
Tuesday, January 26, 2027